Clinical trial
Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe…
NCT00490919 · Purdue Pharma LP, Industry · Completed
Key facts
| NCT number | NCT00490919 |
|---|---|
| Title | Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain |
| Official title | Multi-center, Randomized, Double-blind, Placebo-controlled With Open Label run-in Study Assessing Efficacy, Tolerability, Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naïve Subjects With Moderate to Severe, Chronic Low Back Pain |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Low Back Pain |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal system, Placebo |
| Enrollment | 539 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jun 25, 2007 |
| Last update posted | Sep 10, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: